HDAC6 and Peritoneal Fibrosis: Overall, several clinical trials have proved the effectiveness, security, applicability of selected HDAC6 inhibitors in clinical treatment, which provides opinions and possibilities of the application of HDAC6 inhibitors in peritoneal fibrosis associated with peritoneal dialysis in the future.